Madam Therapeutics closes first financing round to develop novel antibiotics against drug resistant bacteria

August 27, 2018
Madam Therapeutics BV

Madam Therapeutics, a privately-held biotech company that is developing a novel class of antibiotics inspired by the defense mechanisms of the human body, today announced the closing of its first financing round of 1,1M EUR. 

More info on: